Ardanaz E.

Ardanaz E. is a researcher at the German Cancer Research Center (DKFZ) specializing in cancer epidemiology, with a particular focus on nutritional factors and colorectal cancer risk. As part of the Division of Cancer Epidemiology within the Medical Faculty, her work primarily involves analyzing data from large prospective cohort studies, most notably the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Her research portfolio demonstrates expertise in biomarker discovery, dietary patterns, and metabolic risk factors in cancer development and outcomes.

Her research interests center on cancer epidemiology with emphasis on nutritional influences, particularly examining how dietary components, body composition, and metabolic biomarkers affect cancer risk and progression. Recent work has explored the relationship between circulating biomarkers like lipocalin 2, resistin, and fatty acid binding proteins with colorectal cancer outcomes. She has also investigated the role of food processing, amino acid metabolism, and body shape phenotypes in cancer risk across multiple organ sites. Her methodological approach combines epidemiological analysis with metabolomics and genetic data to uncover complex relationships between lifestyle factors and cancer.

Ardanaz E.'s publication record shows a consistent focus on colorectal cancer epidemiology but extends to other cancer sites including breast, renal, and small intestinal cancers. Her work frequently examines sex-specific differences in cancer risk and outcomes, reflecting an understanding of how biological sex influences disease pathways. The research demonstrates strong collaboration within international consortia, particularly with European cohort studies.

Her scientific contributions include numerous publications in high-impact journals such as International Journal of Cancer, BMC Medicine, and The American Journal of Clinical Nutrition. While specific awards aren't documented in the available information, the volume and quality of her publications suggest recognition within the cancer epidemiology community. She has been involved in studies examining the economic burden of lifestyle factors on healthcare systems, demonstrating the translational impact of her epidemiological work.

Ardanaz E. has contributed to research examining the intersection of physical activity, metabolic health, and cancer risk, often collaborating with teams studying the German National Cohort (NAKO). Her work bridges basic science discoveries about molecular pathways with population-level epidemiological evidence, creating a comprehensive understanding of cancer etiology that informs prevention strategies.